KRT19 and intrahepatic cholangiocarcinoma: This model labels KRT19+AXIN2+ cells with tdTomato (Tom) upon tamoxifen administration, enabling the tracking of KRT19+AXIN2+ (Tom+) cell dynamics during ICC tumorigenesis (Figure 2F).